Zhejiang Super Soul Artificial Intelligence Research Institute Co., Ltd. announced that it will received CNY 140,000,000 in an equity round of funding on December 15, 2020. The transaction included participation from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) to retain 100% shares.. After the capital increase is completed, the registered capital of Super Soul has increased from CNY 10,000,000 to CNY 150,000,000. The transaction has been reviewed and approved at the eighth meeting of the fourth board of directors of the company.